Vaxcyte Inc (PCVX) Business News Sept. 03, 2025, 11:31 UTC Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose Full text
There are no comments here yet...